Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview

Pads Palihaderu, Bilm Mendis, Jmkjk Premarathne, Wkrr Dias,Swee Keong Yeap,Wan Yong Ho,A S Dissanayake, I H Rajapakse,P Karunanayake,U Senarath,D A Satharasinghe

EPIGENETICS INSIGHTS(2022)

引用 5|浏览10
暂无评分
摘要
MicroRNA(miRNA)s have been identified as an emerging class for therapeutic interventions mainly due to their extracellularly stable presence in humans and animals and their potential for horizontal transmission and action. However, treating Type 2 diabetes mellitus using this technology has yet been in a nascent state. MiRNAs play a significant role in the pathogenesis of Type 2 diabetes mellitus establishing the potential for utilizing miRNA-based therapeutic interventions to treat the disease. Recently, the administration of miRNA mimics or antimiRs in-vivo has resulted in positive modulation of glucose and lipid metabolism. Further, several cell culture-based interventions have suggested beta cell regeneration potential in miRNAs. Nevertheless, few such miRNA-based therapeutic approaches have reached the clinical phase. Therefore, future research contributions would identify the possibility of miRNA therapeutics for tackling T2DM. This article briefly reported recent developments on miRNA-based therapeutics for treating Type 2 Diabetes mellitus, associated implications, gaps, and recommendations for future studies.
更多
查看译文
关键词
miRNA, therapeutic, miRNA-mimics, antimiRs, metabolism, beta-cell differentiation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要